Ali Mohamed

Ali Mohamed

Company: Immatics

Job title: SVP of CMC


Developing Next-Generation Allogeneic Therapies for Solid Tumors Based on Gamma Delta T cells 2:30 pm

Discussing characteristics of gamma delta T cells as source for an allogeneic cell therapy approach Redirecting gamma delta T cells with TCRs against peptide-HLA targets to combat solid tumors Exploring next-gen strategies to potentiate anti-tumor activityRead more

day: Day Two

Revolutionizing Data Management & Process Integration 11:15 am

Read more

day: Day 2: Supply/Storage

Driving Scalable Manufacturing & Optimizing Characterization for Successful Commercialisation of Allogenic Therapies 11:15 am

Read more

day: Day 2: Manufacturing & CMC

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.